Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of PLEKHA4 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of PLEKHA4 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of PLEKHA4 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | PLEKHA4 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of PLEKHA4 mRNA | CTD | PMID:30165855 | 17beta-estradiol | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of PLEKHA4 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PLEKHA4 mRNA | CTD | PMID:21215274 and PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLEKHA4 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Plekha4 (Rattus norvegicus) | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PLEKHA4 mRNA] | CTD | PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PLEKHA4 mRNA | CTD | PMID:22298810 | 2,4-dinitrotoluene | affects expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of PLEKHA4 mRNA | CTD | PMID:21346803 | 6-propyl-2-thiouracil | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PLEKHA4 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of PLEKHA4 mRNA | CTD | PMID:30047161 | acetamide | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of PLEKHA4 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Tretinoin results in increased expression of PLEKHA4 mRNA | CTD | PMID:20488242 | amitrole | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of PLEKHA4 mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PLEKHA4 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PLEKHA4 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PLEKHA4 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PLEKHA4 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of PLEKHA4 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PLEKHA4 5' UTR | CTD | PMID:27901495 | Benzo[k]fluoranthene | decreases expression | EXP | | 6480464 | benzo(k)fluoranthene results in decreased expression of PLEKHA4 mRNA | CTD | PMID:26377693 | beta-naphthoflavone | multiple interactions | ISO | Plekha4 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLEKHA4 mRNA | CTD | PMID:18164116 | bisphenol A | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PLEKHA4 mRNA | CTD | PMID:25181051 and PMID:35192832 | cadmium atom | multiple interactions | ISO | PLEKHA4 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA4 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | PLEKHA4 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA4 mRNA | CTD | PMID:35301059 | caffeine | decreases phosphorylation | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of PLEKHA4 protein | CTD | PMID:35688186 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of PLEKHA4 mRNA | CTD | PMID:37019170 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEKHA4 mRNA | CTD | PMID:20938992 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of PLEKHA4 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of PLEKHA4 mRNA | CTD | PMID:21266533 | disodium selenite | decreases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of PLEKHA4 mRNA | CTD | PMID:18175754 | doxorubicin | decreases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of PLEKHA4 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of PLEKHA4 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | entinostat results in increased expression of PLEKHA4 mRNA | CTD | PMID:27188386 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEKHA4 mRNA more ... | CTD | PMID:20938992 and PMID:22206623 | FR900359 | increases phosphorylation | ISO | PLEKHA4 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of PLEKHA4 protein | CTD | PMID:37730182 | furan | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | furan results in increased expression of PLEKHA4 mRNA | CTD | PMID:25539665 and PMID:26194646 | gentamycin | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PLEKHA4 mRNA | CTD | PMID:33387578 | ketoconazole | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Ketoconazole results in increased expression of PLEKHA4 mRNA | CTD | PMID:28263823 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEKHA4 mRNA | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | PLEKHA4 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PLEKHA4 mRNA] | CTD | PMID:35811015 | lipopolysaccharide | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of PLEKHA4 mRNA | CTD | PMID:35811015 | N-methyl-4-phenylpyridinium | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of PLEKHA4 mRNA | CTD | PMID:24810058 | N-nitrosodiethylamine | multiple interactions | ISO | Plekha4 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLEKHA4 mRNA | CTD | PMID:18164116 | nickel atom | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Nickel results in increased expression of PLEKHA4 mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PLEKHA4 mRNA | CTD | PMID:33387578 | paraquat | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of PLEKHA4 mRNA | CTD | PMID:32680482 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PLEKHA4 mRNA | CTD | PMID:23811191 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PLEKHA4 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PLEKHA4 mRNA] | CTD | PMID:35811015 | silicon dioxide | decreases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of PLEKHA4 mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PLEKHA4 mRNA | CTD | PMID:29301061 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of PLEKHA4 mRNA | CTD | PMID:37682722 | sulfadimethoxine | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of PLEKHA4 mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of PLEKHA4 mRNA | CTD | PMID:31533062 | temozolomide | increases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of PLEKHA4 mRNA | CTD | PMID:31758290 | thioacetamide | decreases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of PLEKHA4 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of PLEKHA4 mRNA | CTD | PMID:23557971 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of PLEKHA4 mRNA | CTD | PMID:32835833 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of PLEKHA4 mRNA | CTD | PMID:33045310 | valproic acid | decreases expression | ISO | PLEKHA4 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PLEKHA4 mRNA | CTD | PMID:29154799 | vinclozolin | increases expression | ISO | Plekha4 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of PLEKHA4 mRNA | CTD | PMID:20566332 | |